Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1983 May;49(5):442–446. doi: 10.1136/hrt.49.5.442

Coronary haemodynamic effects of nifedipine. Comparison with glyceryl trinitrate.

D L Stone, J D Stephens, S O Banim
PMCID: PMC481330  PMID: 6404288

Abstract

The coronary haemodynamic effects of nifedipine and glyceryl trinitrate were compared in 22 patients undergoing investigations for suspected coronary artery disease. Myocardial blood flow was estimated by the coronary sinus thermodilution technique. In sinus rhythm nifedipine increased mean coronary sinus flow from 135 ml/min to 152 ml/min, and reduced arterio-coronary sinus oxygen difference from 12.4 to 10.96 ml/100 ml without causing a significant change in coronary vascular resistance or in myocardial oxygen consumption. Glyceryl trinitrate reduced mean coronary sinus flow from 165 to 111 ml/min, myocardial oxygen consumption from 19.2 to 11.9 ml/min, and arterio-coronary sinus oxygen difference from 11.7 to 10.9 ml/100 ml. There was a rise in coronary vascular resistance from 54 355 to 74 364 dynes s cm-5. During atrial pacing nifedipine reduced the arterio-coronary sinus oxygen difference from 11.99 to 11.0 ml/100 ml but had no significant effect on the other variables measured. Glyceryl trinitrate caused a fall in mean coronary sinus flow from 207 ml/min to 168 ml/min; myocardial oxygen consumption fell from 24 ml/min to 18 ml/min, while coronary vascular resistance rose from 41 714 to 51 234 dynes s cm-5. Direct comparison of the two drugs showed a significant difference in effects on coronary sinus flow and coronary vascular resistance in sinus rhythm. Both drugs appeared effective in relieving ischaemia as judged by a reduction of the incidence of pacing induced angina and an improvement in lactate status.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anastassiades C. J. Nifedipine and beta-blocker drugs. Br Med J. 1980 Nov 8;281(6250):1251–1252. doi: 10.1136/bmj.281.6250.1251-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antman E., Muller J., Goldberg S., MacAlpin R., Rubenfire M., Tabatznik B., Liang C. S., Heupler F., Achuff S., Reichek N. Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med. 1980 Jun 5;302(23):1269–1273. doi: 10.1056/NEJM198006053022301. [DOI] [PubMed] [Google Scholar]
  3. BERNE R. M. REGULATION OF CORONARY BLOOD FLOW. Physiol Rev. 1964 Jan;44:1–29. doi: 10.1152/physrev.1964.44.1.1. [DOI] [PubMed] [Google Scholar]
  4. Brooks N., Cattell M., Pidgeon J., Balcon R. Unpredictable response to nifedipine in severe cardiac failure. Br Med J. 1980 Nov 15;281(6251):1324–1324. doi: 10.1136/bmj.281.6251.1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Engel H. J., Wolf R., Hundeshagen H., Lichtlen P. R. Different effects of nitroglycerin and nifedipine on regional myocardial blood flow during pacing induced angina pectoris. Eur Heart J. 1980 Dec;1(Suppl B):53–58. doi: 10.1093/eurheartj/1.suppl_2.53. [DOI] [PubMed] [Google Scholar]
  6. Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1977;17:149–166. doi: 10.1146/annurev.pa.17.040177.001053. [DOI] [PubMed] [Google Scholar]
  7. Ganz W., Tamura K., Marcus H. S., Donoso R., Yoshida S., Swan H. J. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971 Aug;44(2):181–195. doi: 10.1161/01.cir.44.2.181. [DOI] [PubMed] [Google Scholar]
  8. Gillmer D. J., Kark P. Pulmonary oedema precipitated by nifedipine. Br Med J. 1980 Jun 14;280(6229):1420–1421. doi: 10.1136/bmj.280.6229.1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henry P. D., Shuchleib R., Clark R. E., Perez J. E. Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile heat and regional muscle shortening. Am J Cardiol. 1979 Oct 22;44(5):817–824. doi: 10.1016/0002-9149(79)90203-0. [DOI] [PubMed] [Google Scholar]
  10. Hillis L. D., Braunwald E. Coronary-artery spasm. N Engl J Med. 1978 Sep 28;299(13):695–702. doi: 10.1056/NEJM197809282991305. [DOI] [PubMed] [Google Scholar]
  11. KATZ L. N., FEINBERG H. The relation of cardiac effort to myocardial oxygen consumption and coronary flow. Circ Res. 1958 Sep;6(5):656–669. doi: 10.1161/01.res.6.5.656. [DOI] [PubMed] [Google Scholar]
  12. Klugmann S., Salvi A., Camerini F. Haemodynamic effects of nifedipine in heart failure. Br Heart J. 1980 Apr;43(4):440–446. doi: 10.1136/hrt.43.4.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kobayashi T., Ito Y., Tawara I. Clinical experience with a new coronary-active substance (BAY 1 1040). Arzneimittelforschung. 1972 Feb;22(2):380–389. [PubMed] [Google Scholar]
  14. Lown B. Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction. Am J Cardiol. 1979 Oct 22;44(5):780–782. doi: 10.1016/0002-9149(79)90196-6. [DOI] [PubMed] [Google Scholar]
  15. Luz P. L., Forrester J. S., Wyatt H. L., Tyberg J. V., Chagrasulis R., Parmley W. W., Swan H. J. Hemodynamic and metabolic effects of sodium nitroprusside on the performance and metabolism of regional ischemic myocardium;. Circulation. 1975 Sep;52(3):400–407. doi: 10.1161/01.cir.52.3.400. [DOI] [PubMed] [Google Scholar]
  16. Mason D. T., Braunwald E. The effects of nitroglycerin and amyl nitrite on arteriolar and venous tone in the human forearm. Circulation. 1965 Nov;32(5):755–766. doi: 10.1161/01.cir.32.5.755. [DOI] [PubMed] [Google Scholar]
  17. Moskowitz R. M., Piccini P. A., Nacarelli G. V., Zelis R. Nifedipine therapy for stable angina pectoris: preliminary results of effects on angina frequency and treadmill exercise response. Am J Cardiol. 1979 Oct 22;44(5):811–816. doi: 10.1016/0002-9149(79)90202-9. [DOI] [PubMed] [Google Scholar]
  18. Polese A., Fiorentini C., Olivari M. T., Guazzi M. D. Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med. 1979 May;66(5):825–830. doi: 10.1016/0002-9343(79)91123-9. [DOI] [PubMed] [Google Scholar]
  19. Robson R. H., Vishwanath M. C. Nifedipine and beta-blockade as a cause of cardiac failure. Br Med J (Clin Res Ed) 1982 Jan 9;284(6309):104–104. doi: 10.1136/bmj.284.6309.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stephens J. D., Hayward R. P., Dymond D. S., Ead H., Adams L., Spurrell R. A. Effects of sodium nitroprusside and phenylephrine on coronary dynamics in patients with normal left ventricular function. Br Heart J. 1979 Apr;41(4):456–462. doi: 10.1136/hrt.41.4.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vater W., Kroneberg G., Hoffmeister F., Saller H., Meng K., Oberdorf A., Puls W., Schlossmann K., Stoepel K. Zur Pharmakologie von 4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester (Nifedipine), BAY a 1040. Arzneimittelforschung. 1972 Jan;22(1):1–14. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES